IL1B and type 2 diabetes mellitus: It has been reported that IL-1β amplified systemic inflammation and impaired insulin signaling leading to insulin resistant (Boni-Schnetzler and Donath, 2013) and organ dysfunction (Grant and Dixit, 2013) in peripheral tissues and macrophages during type 2 diabetes mellitus.